NuPathe to Present at the Cowen and Company 32nd Annual Health Care Conference
(firmenpresse) - CONSHOHOCKEN, PA -- (Marketwire) -- 02/29/12 -- NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, today announced that , chief executive officer, will present a company overview at Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7, 2012, at 8:00 a.m. EST. The conference is being held at the Boston Marriott Copley Place in Boston, MA.
A live audio webcast of the presentation will be available via the "Investor Relations" page of the NuPathe website, . Please log on through NuPathe's website approximately 10 minutes prior to the scheduled start time. A replay of the webcast will also be archived on NuPathe's website for 90 days following the presentation.
Inc. is a biopharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, , is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two additional proprietary product candidates in preclinical development: for the continuous symptomatic treatment of Parkinson's disease, which the company plans to partner, and for the long-term treatment of schizophrenia and bipolar disorder. For more information, please visit our website and our blog at . You can also follow us on StockTwits (), Twitter (), SlideShare (), and LinkedIn ().
John Woolford
Westwicke Partners, LLC
(443) 213-0506
Keith A. Goldan
Vice President & Chief Financial Officer
NuPathe Inc.
(484) 567-0130
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.02.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 1088106
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
CONSHOHOCKEN, PA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 113 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"NuPathe to Present at the Cowen and Company 32nd Annual Health Care Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
NuPathe Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
